Found: 49
Select item for more details and to access through your institution.
Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 inhibitor fit in the management of type 2 diabetes?
- Published in:
- 2015
- By:
- Publication type:
- journal article
Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Response to comment on O'Connor et al. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes care 2014;37:3317-3324.
- Published in:
- 2015
- By:
- Publication type:
- commentary
SGLT2 Inhibitors: The Latest "New Kids on the Block"!
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 352, doi. 10.2337/dc14-3048
- By:
- Publication type:
- Article
Randomized Trial of Telephone Outreach to Improve Medication Adherence and Metabolic Control in Adults With Diabetes. Diabetes Care 2014;37:3317-3324.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Early Hyperglycemia Detected by Continuous Glucose Monitoring in Children at Risk for Type 1 Diabetes. Diabetes Care 2014;37:2031-2033.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Gestational Diabetes Mellitus and the Offspring--Jack and Jill Are Different Still.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 345, doi. 10.2337/dc14-2874
- By:
- Publication type:
- Article
Latent Autoimmune Diabetes in Adults With Low-Titer GAD Antibodies: Similar Disease Progression With Type 2 Diabetes: A Nationwide, Multicenter Prospective Study (LADA China Study 3). Diabetes Care 2015;38:16-21.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Early Hyperglycemia Detected by Continuous Glucose Monitoring in Children at Risk for Type 1 Diabetes. Diabetes Care 2014;37:2031-2033.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Randomized Trial of Telephone Outreach to Improve Medication Adherence and Metabolic Control in Adults With Diabetes. Diabetes Care 2014;37:3317-3324.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Introduction of IADPSG Criteria for the Screening and Diagnosis of Gestational Diabetes Mellitus Results in Improved Pregnancy Outcomes at a Lower Cost in a Large Cohort of Pregnant Women: The St. Carlos Gestational Diabetes Study. Diabetes Care 2014;37:2442-2450.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Latent Autoimmune Diabetes in Adults With Low-Titer GAD Antibodies: Similar Disease Progression With Type 2 Diabetes: A Nationwide, Multicenter Prospective Study (LADA China Study 3). Diabetes Care 2015;38:16-21.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes?
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial. Diabetes Care 2014;37:2427-2434.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Introduction of IADPSG Criteria for the Screening and Diagnosis of Gestational Diabetes Mellitus Results in Improved Pregnancy Outcomes at a Lower Cost in a Large Cohort of Pregnant Women: The St. Carlos Gestational Diabetes Study. Diabetes Care 2014;37:2442-2450.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 394, doi. 10.2337/dc14-2365
- By:
- Publication type:
- Article
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 384, doi. 10.2337/dc14-2364
- By:
- Publication type:
- Article
Mild gestational diabetes mellitus and long-term child health.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Remission of Severe Neonatal Diabetes With Very Early Sulfonylurea Treatment.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Sleep Duration and Risk of Type 2 Diabetes: A Meta-analysis of Prospective Studies.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 529, doi. 10.2337/dc14-2073
- By:
- Publication type:
- Article
Effect of Bariatric Surgery Versus Intensive Medical Management on Diabetic Ophthalmic Outcomes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. e32, doi. 10.2337/dc14-2035
- By:
- Publication type:
- Article
Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 476, doi. 10.2337/dc14-1952
- By:
- Publication type:
- Article
Responding to the challenges of primary diabetes care through the national diabetes education program.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Retinal Thinning as a Marker of Disease Progression in Patients With Wolfram Syndrome.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. e36, doi. 10.2337/dc14-1898
- By:
- Publication type:
- Article
Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. e34, doi. 10.2337/dc14-1874
- By:
- Publication type:
- Article
Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 488, doi. 10.2337/dc14-1778
- By:
- Publication type:
- Article
Tyrosine Phosphatase--Related Islet Antigen 2<sub>(256-760)</sub> Autoantibodies, the OnlyMarker of Islet Autoimmunity That Increases by Increasing the Degree of BMI in Obese Subjects With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 513, doi. 10.2337/dc14-1638
- By:
- Publication type:
- Article
Blood Pressure Reduction: An Added Benefit of Sodium--Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 429, doi. 10.2337/dc14-1596
- By:
- Publication type:
- Article
Life Years Lost and Lifetime Health Care Expenditures Associated With Diabetes in the U.S., National Health Interview Survey, 1997-2000.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 460, doi. 10.2337/dc14-1453
- By:
- Publication type:
- Article
Trends in Diabetes Incidence: The Framingham Heart Study.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 482, doi. 10.2337/dc14-1432
- By:
- Publication type:
- Article
Saul Genuth, MD: Clinical Researcher and Leader in Developing Modern Diabetes Treatment.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 347, doi. 10.2337/dc14-1396
- By:
- Publication type:
- Article
Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium--Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 403, doi. 10.2337/dc14-1237
- By:
- Publication type:
- Article
The Risk of Colorectal Cancer in Patients With Type 2 Diabetes: Associations With Treatment Stage and Obesity.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 495, doi. 10.2337/dc14-1175
- By:
- Publication type:
- Article
Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 376, doi. 10.2337/dc14-1142
- By:
- Publication type:
- Article
Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 420, doi. 10.2337/dc14-1096
- By:
- Publication type:
- Article
How Do People With Diabetes Describe Their Experiences in Primary Care? Evidence From 85,760 Patients With Self-reported Diabetes From the English General Practice Patient Survey.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 469, doi. 10.2337/dc14-1095
- By:
- Publication type:
- Article
Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Patients With Type 2 Diabetes on Metformin Monotherapy.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 431, doi. 10.2337/dc14-0890
- By:
- Publication type:
- Article
Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 365, doi. 10.2337/dc14-0666
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Insulin Glargine Given in the Evening as Compared With in the Morning in Type 2 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 503, doi. 10.2337/dc14-0649
- By:
- Publication type:
- Article
PCSK7 Genotype Modifies Effect of a Weight-Loss Diet on 2-Year Changes of Insulin Resistance: The POUNDS LOST Trial.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 439, doi. 10.2337/dc14-0473
- By:
- Publication type:
- Article
Risks of Psychiatric Disorders and Suicide Attempts in Children and Adolescents With Type 1 Diabetes: A Population-Based Cohort Study.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 453, doi. 10.2337/dc14-0262
- By:
- Publication type:
- Article
Serum 25-Hydroxyvitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 521, doi. 10.2337/dc14-0180
- By:
- Publication type:
- Article
Exploring the Potential of the SGLT2 Inhibitor Dapaglif lozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 412, doi. 10.2337/dc13-2955
- By:
- Publication type:
- Article
Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 355, doi. 10.2337/dc13-2762
- By:
- Publication type:
- Article
In This Issue of Diabetes Care.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 341, doi. 10.2337/dc15-ti03
- Publication type:
- Article
ADA EVENTS.
- Published in:
- 2015
- Publication type:
- Calendar
Erratum.
- Published in:
- 2015
- Publication type:
- Correction Notice